CA
RMD icon

CXI Advisors’s ResMed RMD Stock Holding History

CXI Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$18K Buy
+115
New +$16.6K 0.04% 58

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CXI Advisors's RMD Position: Q4 2019 in Review

CXI Advisors opened a new position in ResMed (RMD) in Q4 2019: 115 shares worth $18K. The stake represents 0.04% of the portfolio and ranks #58 among its holdings.

560 funds tracked by Wall St. Rank hold RMD as of Q4 2019.

  • CXI Advisors held 115 shares of ResMed worth $18K as of Q4 2019.
  • ResMed was a new CXI Advisors position in Q4 2019.
  • ResMed made up 0.04% of CXI Advisors's portfolio in Q4 2019, its #58 holding.
  • 560 funds tracked by Wall St. Rank held ResMed as of Q4 2019.

Based on CXI Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.